LANCRIX

Elacridar, ≥98%

Catalog No. 227345

Identification
SynonymsGF120918, GG918, GW0918
CAS No.143664-11-3
M.F.

C34H33N3O5

M.W.563.64
MDL No.MFCD00912604
Technical Data
Assay≥98% HPLC
SolubilityDMSO
Storage-20℃
ApplicationElacridar is a potent inhibitor of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP).
Safety Data
Reference

Bankstahl JP, et al. Drug Metab Dispos. 2013 Apr;41(4):754-62
Durmus S, et al. Mol Pharm. 2012 Nov 5;9(11):3236-45
Sane R, et al. Drug Metab Dispos. 2012 Aug;40(8):1612-9
Kuppens IE, et al. Clin Cancer Res. 2007 Jun 1;13(11):3276-85

Availability: Ships in 1-3 days

For research use only.

Inquire

(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject 227345, Elacridar, ≥98%, 143664-11-3
*Message
*Code If it’s not clear, please click on the picture to change one.